PIK3CA and neoplasm: ddPCR has been applied to quantify oncogene mutations in ctDNA, such as PIK3CA mutations in early-stage breast cancer, achieving a sensitivity of 0.01 % for detecting each of the three PIK3CA hotspot mutations and a specificity exceeding 99 % compared to tumor tissue [10].